Skip to main content
Top
Published in: Osteoporosis International 9/2005

01-09-2005 | Original Article

Decreased bone mineral density in patients with neurofibromatosis 1

Authors: Marga Lammert, Martin Kappler, Victor-Felix Mautner, Kurt Lammert, Stephan Störkel, Jan M. Friedman, Derek Atkins

Published in: Osteoporosis International | Issue 9/2005

Login to get access

Abstract

Neurofibromatosis 1 (NF1) is one of the most common autosomal dominant diseases. Although there is a considerable variability in clinical expression, NF1 is almost fully penetrant in adult patients and may be associated with a variety of skeletal anomalies. Spinal deformities are the most common skeletal manifestation, with an incidence estimated from 10–25% in various studies. Some NF1 patients have a dystrophic form of scoliosis, which is characterized by early age at onset and rapid progression. Complications have been reported during spinal instrumentation of dystrophic curves due to soft, non-resistant vertebral bony tissue, suggesting that an alteration of bone quality may occur in NF1 patients. Recent studies have suggested that decreased bone mineral density (BMD) may occur among patients with NF1. We performed a cross-sectional study on 104 adults with NF1, using quantitative ultrasonometry (QUS) to investigate whether decreased BMD is a general phenomenon in NF1 patients. The data reveal that BMD, as measured by age- and gender- adjusted Z-scores, is significantly lower in NF1 patients than in the normal reference population. The decrease in BMD appears to be even more marked among NF1 patients with scoliosis that requires surgical treatment. The findings indicate that NF1 produces a generalized alteration of bone in addition to the focal osseous dysplasias of the vertebrae, tibia, and sphenoid wing that characterize this condition. The pathological mechanism underlying these bony changes remains to be elucidated.
Literature
1.
go back to reference Rasmussen SA, Friedman JM (2000) NF1 gene and neurofibromatosis 1. Am J Epidemiol 151:33–40PubMed Rasmussen SA, Friedman JM (2000) NF1 gene and neurofibromatosis 1. Am J Epidemiol 151:33–40PubMed
2.
go back to reference Cichovski K, Jacks T (2001) NF1 tumor suppressor gene function: narrowing the GAP. Cell 104:593–604PubMed Cichovski K, Jacks T (2001) NF1 tumor suppressor gene function: narrowing the GAP. Cell 104:593–604PubMed
3.
go back to reference DeClue JE, Cohen BD, Lowy DR (1991) Identification and characterization of the neurofibromatosis type 1 protein product. Proc Natl Acad Sci U S A 88:9914–9918 DeClue JE, Cohen BD, Lowy DR (1991) Identification and characterization of the neurofibromatosis type 1 protein product. Proc Natl Acad Sci U S A 88:9914–9918
4.
go back to reference Legius E, Marchuk DA, Collins FS, Glover TW (1993) Somatic deletion of the neurofibromatosis type 1 gene in a neurofibrosarcoma supports a tumor suppressor gene hypothesis. Nat Genet 3:122–126PubMed Legius E, Marchuk DA, Collins FS, Glover TW (1993) Somatic deletion of the neurofibromatosis type 1 gene in a neurofibrosarcoma supports a tumor suppressor gene hypothesis. Nat Genet 3:122–126PubMed
5.
go back to reference Kluwe L, Friedrich RE, Mautner VF (1999) Allelic loss of the NF1 gene in NF1-associated plexiform neurofibromas. Cancer Genet Cytogenet 113:65–69CrossRefPubMed Kluwe L, Friedrich RE, Mautner VF (1999) Allelic loss of the NF1 gene in NF1-associated plexiform neurofibromas. Cancer Genet Cytogenet 113:65–69CrossRefPubMed
6.
go back to reference National Institutes of Health (1988) Neurofibromatosis. Conference statement. National Institutes of Health Consensus Development Conference. Arch Neurol 45:575–578PubMed National Institutes of Health (1988) Neurofibromatosis. Conference statement. National Institutes of Health Consensus Development Conference. Arch Neurol 45:575–578PubMed
7.
go back to reference Crawford AH (1994) Neurofibromatosis. In: Weinstein SL (ed) The pediatric spine. Raven Press, New York, pp 619–649 Crawford AH (1994) Neurofibromatosis. In: Weinstein SL (ed) The pediatric spine. Raven Press, New York, pp 619–649
8.
go back to reference Kim HW, Weinstein SL (1997) The management of scoliosis in neuro-fibromatosis. Spine 22:2770–2776PubMed Kim HW, Weinstein SL (1997) The management of scoliosis in neuro-fibromatosis. Spine 22:2770–2776PubMed
9.
go back to reference Illés T, Hlalmai V, de Jonge T, Dubousset J (2001) Decreased bone mineral density in neurofibromatosis-1 patients with spinal deformities. Osteoporosis Int 12:823–827CrossRef Illés T, Hlalmai V, de Jonge T, Dubousset J (2001) Decreased bone mineral density in neurofibromatosis-1 patients with spinal deformities. Osteoporosis Int 12:823–827CrossRef
10.
go back to reference Brunetti-Pierri N, Phan K, Carter S, Lewis RA, Plon S, Ellis KJ, O’Brian SE, Lee B (2003) Generalized osteopenia in neurofibromatosis type 1 patients points to an underlying disorder of skeletal homeostasis and mineralization. Am J Hum Genet 73:261PubMed Brunetti-Pierri N, Phan K, Carter S, Lewis RA, Plon S, Ellis KJ, O’Brian SE, Lee B (2003) Generalized osteopenia in neurofibromatosis type 1 patients points to an underlying disorder of skeletal homeostasis and mineralization. Am J Hum Genet 73:261PubMed
11.
go back to reference Lane JM, Russel L, Khan S (2000) Osteoporosis. Clin Orthop 372:139–150PubMed Lane JM, Russel L, Khan S (2000) Osteoporosis. Clin Orthop 372:139–150PubMed
12.
go back to reference WHO Study Group (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Technical report series 843: WHO, Geneva WHO Study Group (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Technical report series 843: WHO, Geneva
13.
go back to reference Hans D, Dargent-Molina P, Schott AM, Sebert JL, Cormier C, Kotzki PO, Delmas PD, Pouilles JM, Breart G, Meunier PJ (1996) Ultrasonographic heel measurements to predict hip fracture in elderly women: the EPIDOS prospective study. Lancet 348:511–514CrossRefPubMed Hans D, Dargent-Molina P, Schott AM, Sebert JL, Cormier C, Kotzki PO, Delmas PD, Pouilles JM, Breart G, Meunier PJ (1996) Ultrasonographic heel measurements to predict hip fracture in elderly women: the EPIDOS prospective study. Lancet 348:511–514CrossRefPubMed
14.
go back to reference Schott AM, Weill-Engerer S, Hans D, Duboef F, Delams P, Meunier P (1995) Ultrasound discriminates patients with hip fracture equally well as dual energy X-ray absorptiometry and independently of bone mineral density. J Bone Miner Res 10:243–249PubMed Schott AM, Weill-Engerer S, Hans D, Duboef F, Delams P, Meunier P (1995) Ultrasound discriminates patients with hip fracture equally well as dual energy X-ray absorptiometry and independently of bone mineral density. J Bone Miner Res 10:243–249PubMed
15.
go back to reference Bennell KL, Harp P, Nattrass C, Wark JD (1998) Acute and subacute changes in the ultrasound measurements of the calcaneus following intense exercise. Calcif Tissue Int 63:505–509PubMed Bennell KL, Harp P, Nattrass C, Wark JD (1998) Acute and subacute changes in the ultrasound measurements of the calcaneus following intense exercise. Calcif Tissue Int 63:505–509PubMed
16.
go back to reference Kang C, Speller R (1998) Comparison of ultrasound and dual energy X-ray absorptiometry measurements in the calcaneus. Br J Radiol 71:861–867 Kang C, Speller R (1998) Comparison of ultrasound and dual energy X-ray absorptiometry measurements in the calcaneus. Br J Radiol 71:861–867
17.
go back to reference Wüster C, Hadji P (2001) Use of quantitative ultrasound densitometry (QUS) in male osteoporosis. Calcif Tissue Int 69:225–228PubMed Wüster C, Hadji P (2001) Use of quantitative ultrasound densitometry (QUS) in male osteoporosis. Calcif Tissue Int 69:225–228PubMed
18.
go back to reference Hadji P, Kalder M, Backhus J, Gottschalk M, Hars O, Schulz KD (2002) Age-associated changes in bone ultrasonometry of the os calcis. J Clin Densitom 5:297–303PubMed Hadji P, Kalder M, Backhus J, Gottschalk M, Hars O, Schulz KD (2002) Age-associated changes in bone ultrasonometry of the os calcis. J Clin Densitom 5:297–303PubMed
19.
go back to reference Dachverband Deutschsprachiger Wissenschaftlicher Gesellschaften für Osteologie (DVO) (2002) Postmenopausal Osteoporosis Dachverband Deutschsprachiger Wissenschaftlicher Gesellschaften für Osteologie (DVO) (2002) Postmenopausal Osteoporosis
20.
go back to reference Huson SM (1994) Neurofibromatosis 1: a clinical and genetic overview. In: Huson SM, Hughes RAC (eds) The neurofibromatoses: a pathogenetic and clinical overview. Chapman and Hall Medical, London, pp 160–203 Huson SM (1994) Neurofibromatosis 1: a clinical and genetic overview. In: Huson SM, Hughes RAC (eds) The neurofibromatoses: a pathogenetic and clinical overview. Chapman and Hall Medical, London, pp 160–203
21.
go back to reference Friedman JM, Birch PH (1997) Type 1 neurofibromatosis: a descriptive analysis of the disorder in 1,728 patients. Am J Med Genet 70:138–143PubMed Friedman JM, Birch PH (1997) Type 1 neurofibromatosis: a descriptive analysis of the disorder in 1,728 patients. Am J Med Genet 70:138–143PubMed
22.
go back to reference Jakes RW, Khaw K, Day NE, Bingham S, Welch A, Oakes S, Luben R, Dalzell N, Reeve J, Wareham NJ (2001) Patterns of physical activity and ultrasound attenuation by heel bone among Norfolk cohort of European Prospective Investigation of Cancer (EPIC Norfolk): population based study. BMJ 322:140PubMed Jakes RW, Khaw K, Day NE, Bingham S, Welch A, Oakes S, Luben R, Dalzell N, Reeve J, Wareham NJ (2001) Patterns of physical activity and ultrasound attenuation by heel bone among Norfolk cohort of European Prospective Investigation of Cancer (EPIC Norfolk): population based study. BMJ 322:140PubMed
23.
go back to reference Adami S, Giannini S, Giorgino R, Isaia G, Maggi S, Sinigaglia L, Filipponi P, Crepaldi G, Di Munno O (2003) The effect of age, weight, and lifestyle factors on calcaneal quantitative ultrasound: the ESOPO study. Osteoporos Int 14:198–207PubMed Adami S, Giannini S, Giorgino R, Isaia G, Maggi S, Sinigaglia L, Filipponi P, Crepaldi G, Di Munno O (2003) The effect of age, weight, and lifestyle factors on calcaneal quantitative ultrasound: the ESOPO study. Osteoporos Int 14:198–207PubMed
24.
go back to reference Macfarlane R, Levin AV, Weksberg R, Blaser S, Rutka JT (1995) Absence of the greater sphenoid wing in neurofibromatosis type I, congenital or acquired: case report. Neurosurgery 37:129–133PubMed Macfarlane R, Levin AV, Weksberg R, Blaser S, Rutka JT (1995) Absence of the greater sphenoid wing in neurofibromatosis type I, congenital or acquired: case report. Neurosurgery 37:129–133PubMed
25.
go back to reference Hefti F, Bollini G, Dungl P, Fixsen J, Grill F, Ippolito E, Romanus B, Tudisco C, Wientroub S (2000) Congenital pseudarthrosis of the tibia: history, etiology, classification, and epidemiologic data. J Pediatr Orthop B 9:11–15 Hefti F, Bollini G, Dungl P, Fixsen J, Grill F, Ippolito E, Romanus B, Tudisco C, Wientroub S (2000) Congenital pseudarthrosis of the tibia: history, etiology, classification, and epidemiologic data. J Pediatr Orthop B 9:11–15
26.
go back to reference Ippolito E, Corsi A, Grill F, Wientroub S, Bianco P (2000) Pathology of bone lesions associated with congenital pseudarthrosis of the leg. J Pediatr Orthop B 9:3–10 Ippolito E, Corsi A, Grill F, Wientroub S, Bianco P (2000) Pathology of bone lesions associated with congenital pseudarthrosis of the leg. J Pediatr Orthop B 9:3–10
27.
go back to reference Jacquemin C, Bosley TM, Svedberg H (2003) Orbit deformities in craniofacial neurofibromatosis type 1. AJNR Am J Neuroradiol 24:1678–1682PubMed Jacquemin C, Bosley TM, Svedberg H (2003) Orbit deformities in craniofacial neurofibromatosis type 1. AJNR Am J Neuroradiol 24:1678–1682PubMed
28.
go back to reference Lambert J, Lips P (1989) Adult hypophosphataemic osteomalacia with Fanconi syndrome presenting in a patient with neurofibromatosis. Neth J Med 35:309–316PubMed Lambert J, Lips P (1989) Adult hypophosphataemic osteomalacia with Fanconi syndrome presenting in a patient with neurofibromatosis. Neth J Med 35:309–316PubMed
29.
go back to reference Girschick HJ, Schneider P, Kruse K, Huppertz HI (1999) Bone metabolism and bone mineral density in childhood hypophosphatasia. Bone 25:361–7.PubMed Girschick HJ, Schneider P, Kruse K, Huppertz HI (1999) Bone metabolism and bone mineral density in childhood hypophosphatasia. Bone 25:361–7.PubMed
30.
go back to reference Kuorilehto T, Nissinen M, Koivunen J, Benson MD, Peltonen J (2004) NF1 tumor suppressor protein and mRNA in skeletal tissues of developing and adult normal mouse and NF1-deficient embryos. J Bone Miner Res 19:983–989PubMed Kuorilehto T, Nissinen M, Koivunen J, Benson MD, Peltonen J (2004) NF1 tumor suppressor protein and mRNA in skeletal tissues of developing and adult normal mouse and NF1-deficient embryos. J Bone Miner Res 19:983–989PubMed
Metadata
Title
Decreased bone mineral density in patients with neurofibromatosis 1
Authors
Marga Lammert
Martin Kappler
Victor-Felix Mautner
Kurt Lammert
Stephan Störkel
Jan M. Friedman
Derek Atkins
Publication date
01-09-2005
Publisher
Springer-Verlag
Published in
Osteoporosis International / Issue 9/2005
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-005-1940-2

Other articles of this Issue 9/2005

Osteoporosis International 9/2005 Go to the issue